News & Updates

MAQUET was granted FDA 510(k) clearance for the Volista Surgical Lighting System.

With Intrabeam radiotherapy, either the tumor itself, or the tumor margins are locally irradiated.

The new optional DICOM software program incorporates the Atomlab 960 Thyroid Uptake System.

EIZO is a market leader in display technology.

Acertara’s quality management system has been awarded the ISO certifications.

Bespoke Modeling gives medical professionals the power to diagnose and communicate more effectively.

Innovation and new technology continue to offer real solutions for athletes who incur brain injuries.

FUJIFILM SonoSite Inc. recently announced CE mark approval for its newest generation of point-of-care ultrasound.

Silent Scan is commercially available and growing in clinical adoption around the world.

FDA RECALLS Company: HeartSine Technologies Product(s): Samaritan 300/300P PAD Public Access Defibrillators: Recall – Power, Battery Issues Audience: Consumer Issue: Certain Samaritan 300/300P PAD devices manufactured before December 2010 have been found to intermittently turn on and off, which may eventually deplete the battery. In addition and separately, certain Samaritan 300/300P PAD devices containing early […]

MAQUET was granted FDA 510(k) clearance for the Volista Surgical Lighting System.

With Intrabeam radiotherapy, either the tumor itself, or the tumor margins are locally irradiated.

The new optional DICOM software program incorporates the Atomlab 960 Thyroid Uptake System.

EIZO is a market leader in display technology.

Acertara’s quality management system has been awarded the ISO certifications.

Bespoke Modeling gives medical professionals the power to diagnose and communicate more effectively.

Innovation and new technology continue to offer real solutions for athletes who incur brain injuries.

FUJIFILM SonoSite Inc. recently announced CE mark approval for its newest generation of point-of-care ultrasound.

Silent Scan is commercially available and growing in clinical adoption around the world.

FDA RECALLS Company: HeartSine Technologies Product(s): Samaritan 300/300P PAD Public Access Defibrillators: Recall – Power, Battery Issues Audience: Consumer Issue: Certain Samaritan 300/300P PAD devices manufactured before December 2010 have been found to intermittently turn on and off, which may eventually deplete the battery. In addition and separately, certain Samaritan 300/300P PAD devices containing early […]